Caprion Pharmaceuticals Inc.
Bronze Sponsor
Caprion provides proteomics and immune monitoring services to pharmaceutical and biotechnology companies in a GCP/GLP/GCLP complaint environment. Its immune monitoring division, ImmuneCartaR, offers multiparametric flow cytometry for analyses of innate and adaptive immune responses. Caprion's proteomics division, ProteoCartaTM, offers gel-free, label-free mass spectrometry for comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for discovery and validation of protein biomarkers. The unique integration provides unique value to preclinical and clinical phases of drug development.
Our technology platforms are applicable to all therapeutic areas, including Cancer, Autoimmune, Cardiovascular and Metabolic, Neurology and Infectious Diseases. Our processes utilize all sample types (plasma, serum, CSF, cells, tissue, formalin fixed paraffin embedded, sputum).
Standardized procedures provide our clients with reproducible data that are routinely validated across large sets of clinical samples with rapid development and deployment MRM (Multiple Reaction Monitoring) assays.
Analysis of phenotypic and functional profiles of innate and adaptive immune responses, allows our clients to apply Caprion's multiparametric immune monitoring expertise across many therapeutic areas, including cancer immunotherapy, vaccine development and chronic inflammatory diseases.
Results from our many studies has provided validation of Caprion's robust and industrialized proteomics and immune monitoring approach to preclinical and clinical phases of drug development.
Our technology platforms are applicable to all therapeutic areas, including Cancer, Autoimmune, Cardiovascular and Metabolic, Neurology and Infectious Diseases. Our processes utilize all sample types (plasma, serum, CSF, cells, tissue, formalin fixed paraffin embedded, sputum).
Standardized procedures provide our clients with reproducible data that are routinely validated across large sets of clinical samples with rapid development and deployment MRM (Multiple Reaction Monitoring) assays.
Analysis of phenotypic and functional profiles of innate and adaptive immune responses, allows our clients to apply Caprion's multiparametric immune monitoring expertise across many therapeutic areas, including cancer immunotherapy, vaccine development and chronic inflammatory diseases.
Results from our many studies has provided validation of Caprion's robust and industrialized proteomics and immune monitoring approach to preclinical and clinical phases of drug development.
Co-located with Biomarkers World Europe:
